Hypotony maculopathy, characterized by chorioretinal folds with potential for vision loss, can occur as a complication from overfiltration following trabeculectomy. Its rate has increased in the era of antifibrotics. The challenge in treatment involves raising intraocular pressure to treat hypotony maculopathy while maintaining a level low enough to control glaucoma progression. This review aims to cover the expanse of nonsurgical and surgical management options available. Since a gold standard for hypotony maculopathy treatment is not established, selecting and tailoring treatment options will depend on specific patient and bleb characteristics.
Zeng et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: